AmerisourceBergen Corp. (NYSE:ABC) insider Peyton R. Howell sold 17,800 shares of AmerisourceBergen stock in a transaction that occurred on Thursday, December 14th. The shares were sold at an average price of $89.70, for a total transaction of $1,596,660.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

AmerisourceBergen Corp. (NYSE ABC) traded up $3.86 during mid-day trading on Friday, reaching $93.17. 4,153,406 shares of the company traded hands, compared to its average volume of 1,805,361. The company has a quick ratio of 0.48, a current ratio of 0.91 and a debt-to-equity ratio of 1.83. AmerisourceBergen Corp. has a 1 year low of $71.90 and a 1 year high of $97.85. The company has a market cap of $19,295.90, a PE ratio of 15.02, a PEG ratio of 1.53 and a beta of 1.00.

AmerisourceBergen (NYSE:ABC) last posted its quarterly earnings data on Thursday, November 2nd. The company reported $1.33 earnings per share for the quarter, topping the consensus estimate of $1.32 by $0.01. AmerisourceBergen had a net margin of 0.27% and a return on equity of 56.29%. The firm had revenue of $39.12 billion during the quarter, compared to analysts’ expectations of $40.10 billion. During the same quarter in the previous year, the company posted $1.30 EPS. AmerisourceBergen’s revenue was up 4.2% on a year-over-year basis. equities research analysts anticipate that AmerisourceBergen Corp. will post 6.07 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Monday, December 4th. Shareholders of record on Monday, November 20th were given a dividend of $0.38 per share. This is a boost from AmerisourceBergen’s previous quarterly dividend of $0.37. The ex-dividend date of this dividend was Friday, November 17th. This represents a $1.52 annualized dividend and a dividend yield of 1.63%. AmerisourceBergen’s payout ratio is presently 82.16%.

Several institutional investors have recently modified their holdings of the business. Burgundy Asset Management Ltd. raised its position in shares of AmerisourceBergen by 1.9% during the 3rd quarter. Burgundy Asset Management Ltd. now owns 2,698,948 shares of the company’s stock valued at $223,338,000 after acquiring an additional 49,825 shares during the last quarter. Steward Partners Investment Advisory LLC bought a new stake in shares of AmerisourceBergen during the 3rd quarter valued at $364,000. Coastline Trust Co grew its holdings in shares of AmerisourceBergen by 37.2% in the 3rd quarter. Coastline Trust Co now owns 2,950 shares of the company’s stock valued at $244,000 after buying an additional 800 shares during the period. Gyroscope Capital Management Group LLC grew its holdings in shares of AmerisourceBergen by 9.3% in the 3rd quarter. Gyroscope Capital Management Group LLC now owns 67,695 shares of the company’s stock valued at $5,602,000 after buying an additional 5,773 shares during the period. Finally, IFM Investors Pty Ltd acquired a new position in shares of AmerisourceBergen in the 3rd quarter valued at $406,000. Institutional investors own 67.94% of the company’s stock.

A number of research analysts have recently issued reports on the stock. Goldman Sachs Group upgraded shares of AmerisourceBergen from a “neutral” rating to a “buy” rating in a research note on Friday. Cowen set a $107.00 target price on shares of AmerisourceBergen and gave the company a “buy” rating in a research note on Tuesday. Robert W. Baird set a $99.00 target price on shares of AmerisourceBergen and gave the company a “buy” rating in a research note on Friday, December 1st. Deutsche Bank assumed coverage on shares of AmerisourceBergen in a research note on Monday, December 4th. They issued a “buy” rating and a $97.00 target price for the company. Finally, Morgan Stanley cut shares of AmerisourceBergen from an “overweight” rating to an “equal weight” rating in a research note on Thursday, September 14th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $93.20.

ILLEGAL ACTIVITY WARNING: This story was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of United States and international copyright and trademark legislation. The legal version of this story can be accessed at https://www.watchlistnews.com/peyton-r-howell-sells-17800-shares-of-amerisourcebergen-corp-abc-stock/1766688.html.

About AmerisourceBergen

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.

Insider Buying and Selling by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.